ISTARI ONCOLOGY
Istari Oncology is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. The Company was founded in 2016 by Darell Bigner, MD, and Matthias Gromeier, MD to continue research and clinical development of technology discovered at Duke University.
ISTARI ONCOLOGY
Industry:
Biotechnology Health Care Medical
Founded:
2014-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.istarioncology.com
Total Employee:
11+
Status:
Active
Contact:
(919)226-3082
Email Addresses:
[email protected]
Total Funding:
48.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Global Site Tag
Similar Organizations
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Watchmaker Genomics
Watchmaker Genomics is a biotechnology company that focuses on breakthrough applications for reading, writing, and editing DNA.
Current Employees Featured
Founder
Official Site Inspections
http://www.istarioncology.com Semrush global rank: 5.17 M Semrush visits lastest month: 1.56 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Istari Oncology"
CONTACT US - Istari Oncology
Organization I am a* Investigator Investor Media Representative Patient/Caregiver Other I am most interested in* Lerapolturev clinical trials Istari’s science and data Istari’s news and events …See details»
Who We Are - Istari Oncology
Istari Oncology, Inc., is a clinical-stage biotechnology company developing innovative immunotherapies for the treatment of patients with solid tumors. Istari has built a passionate …See details»
Istari Oncology - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (919)226-3082 Istari Oncology is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy …See details»
Istari Oncology - Overview, News & Similar companies - ZoomInfo
Istari Oncology contact info: Phone number: (919) 245-7662 Website: www.istarioncology.com What does Istari Oncology do? Istari Oncology, Inc., headquartered in Morrisville, North …See details»
Istari Oncology Information - RocketReach
Istarioncology.com; pwc.com; 1 484341XXXX; View Similar People. Related Companies Cultures for Health Inc. 4 $6.2m Carolina Components Group, Inc. 61 $5m Kymanox. 247 $23.3m …See details»
Istari Oncology Enters Into Manufacturing Agreement With …
Oct 26, 2021 For more information, please visit: https://www.istarioncology.com. About FUJIFILM Diosynth Biotechnologies FUJIFILM Diosynth Biotechnologies an industry-leading …See details»
Istari Oncology - Company Profile - Tracxn
Aug 17, 2021 Istari Oncology - Developer of viral vaccines and antibody drug conjugates for the treatment of cancer. Raised a total funding of $48.6M over 3 rounds from 1 investor. Founded …See details»
Istari Oncology - PitchBook
Istari Oncology General Information Description. Operator of a biotechnology company intended to offer treatment of glioblastoma and a wide variety of tumors. The company's platform …See details»
Board of Directors - Istari Oncology
Matthew R. Stober is the President and Chief Executive Officer of Istari Oncology. With more than 30 years of leadership experience at large, multinational pharmaceutical organizations, Mr. …See details»
Istari Oncology - Craft
Istari Oncology has 5 employees across 3 locations and $5.1 m in total funding,. See insights on Istari Oncology including office locations, competitors, revenue, financials, executives, …See details»
Istari Oncology Company Profile | Management and Employees …
[email protected]: Istari Oncology Top Competitors. Company Employees Revenue Top technologies; Syndax Pharmaceuticals. 59: $139.3 M: ArQule Inc. 34: $2.4 M: Polynoma LLC. …See details»
Istari Oncology Enters Into Manufacturing Agreement With …
Oct 26, 2021 FUJIFILM Diosynth Biotechnologies is a leading Contract Development and Manufacturing Organization (CDMO) with experience in the development and manufacture of …See details»
Istari Oncology - LinkedIn
Istari Oncology, Inc. is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of …See details»
Management Team - Istari Oncology
Garrett Nichols, MD, MS, is the Consulting Medical Officer at Istari Oncology. With more than 20 years in the life sciences industry, Dr. Nichols brings vast experience managing the global …See details»
Istari Oncology CEO and Key Executive Team | Craft.co
Istari Oncology's Chairman of the Board is Sean P. Nolan. Other executives include Garrett Nichols, Chief Medical Officer; Jamie Iudica, Chief Manufacturing Officer and 7 others. See the …See details»
Istari Oncology Enters Into Manufacturing Agreement With
Oct 26, 2021 Christine Jackman FUJIFILM Holdings America Corporation 9142614959 [email protected] JP Wallace Istari Oncology (619) 200-7856 …See details»
Istari Oncology Hires Jamie Iudica as Chief Manufacturing Officer ...
Jun 10, 2021 For more information, please visit: www.istarioncology.com. Contacts. Istari Oncology Medical Affairs Contact: ... CheckOrphan is a non-profit organization located in …See details»
Istari Oncology Enters Into Manufacturing Agreement With …
FUJIFILM Diosynth Biotechnologies an industry-leading Biologics Contract Development and Manufacturing Organization (CDMO) with locations in Teesside, UK, RTP, North Carolina, …See details»
Careers - Istari Oncology
If you are interested in joining Istari, review our open positions and apply via the links below. We will contact you directly to kick off our interview process. For future consideration, we invite …See details»